Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion-Reference-Cited by-同舟云学术

Therapeutic Ablation of Gain-of-Function Mutant p53 in Colorectal Cancer Inhibits Stat3-Mediated Tumor Growth and Invasion

Published:2018-08 Issue:2 Volume:34 Page:298-314.e7
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Schulz-Heddergott Ramona,Stark Nadine,Edmunds Shelley J.,Li Jinyu,Conradi Lena-Christin,Bohnenberger Hanibal,Ceteci Fatih,Greten Florian R.,Dobbelstein Matthias,Moll Ute M.

Funder

NIH

Deutsche Forschungsgemeinschaft

Wilhelm Sander-Stiftung

Stony Brook Foundation

German Cancer Aid

Deutsche José Carreras Stiftung

Else Kröner-Fresenius-Stiftung

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference52 articles.

1. A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis;Adorno;Cell,2009

2. p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo;Alexandrova;Cell Death Dis.,2017

3. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment;Alexandrova;Nature,2015

4. Ptpn11/Shp2 acts as a tumor suppressor in hepatocellular carcinogenesis;Bard-Chapeau;Cancer Cell,2011

5. High resolution colonoscopy in live mice;Becker;Nat. Protoc.,2006

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin D3 Upregulated Protein 1 Deficiency Promotes Azoxymethane/Dextran Sulfate Sodium-Induced Colorectal Carcinogenesis in Mice;Cancers;2024-08-23

2. Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within interleukin-6 family cytokines;Cell Reports;2024-08

3. Post-Translational Modifications (PTMs) of mutp53 and Epigenetic Changes Induced by mutp53;Biology;2024-07-08

4. Deciphering the significance of p53 mutant proteins;Trends in Cell Biology;2024-07

5. Thrombocytopenia and hyperprogression after radiotherapy and camrelizumab treatment in an esophageal cancer patient with increased JAK2 gene copies: a case report;Frontiers in Oncology;2024-06-21